Biotech Co. Accuses Citadel Securities, Others Of Spoofing

By Sarah Jarvis · December 1, 2022, 8:31 PM EST

Northwest Biotherapeutics Inc. on Thursday sued several broker-dealers including Citadel Securities LLC and Canaccord Genuity LLC in New York federal court for allegedly carrying out a spoofing scheme that repeatedly drove the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC et al

Case Number

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

December 01, 2022

Recent Articles By Sarah

July 19, 2024
DaVita To Pay $34M In Medicare Kickback Whistleblower Suit
June 28, 2024
Ontrak Exec Conviction Shows Trading Plans Aren't Shields
April 15, 2024
Mental Health Co. Cerebral To Pay $7M Over Data Failures
March 12, 2024
2nd Circ. Revives Parts Of McKesson Whistleblower Suit
March 11, 2024
Pfizer Slams Ex-Compliance Officer's Whistleblower Claims
October 10, 2023
Justices Hint At Siding With Whistleblower Against UBS
October 06, 2023
5 Things To Know About High Court Whistleblower Case
September 13, 2023
Biz Groups Urge CFPB To Not Go After Medical Credit Cards
July 28, 2023
The Compliance Chiefs Who've Faced Legal Hot Water In '23
June 29, 2023
Pharma CEO, Others Get Prison Time In $80M Medicare Fraud